Immunochemical detection of lipid hydroperoxide- and aldehyde-modified proteins in diseases

Sub-Cellular Biochemistry

Volumn 77, Issue , 2014, Pages 115-125

  Sugiyama, Akihiko ^a   Sun, Jing ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Aldehyde; Immunohistochemistry; Lipid hydroperoxide; Oxidation; Polyunsaturated fatty acid

Indexed keywords

ANIMALIA;

ALDEHYDE; LIPID PEROXIDE; LYSINE; UNSATURATED FATTY ACID;

ALZHEIMER DISEASE; HUMAN; LIPID PEROXIDATION; METABOLISM; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOLOGY; PROTEIN PROCESSING;

ALDEHYDES; ALZHEIMER DISEASE; FATTY ACIDS, UNSATURATED; HUMANS; LIPID PEROXIDATION; LIPID PEROXIDES; LYSINE; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84899778914     PISSN: 03060225     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-94-007-7920-4_10     Document Type: Article

References (65)

1. Aray I, Safirstein RL (2003) Cisplatin nephrotoxicity. Semin Nephrol 23:460-464
2. Bernhard D, Wang XL (2007) Smoking, oxidative stress and cardiovascular diseases-do antioxidative therapies fail? Curr Med Chem 14:1703-1712
3. Bessems JG, Vermeulen NP (2001) Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches. Crit Rev Toxicol 31:55-138
4. Calingasan NY, Uchida K, Gibson GE (1999) Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer’s disease. J Neurochem 72:751-756
5. Castellani RJ, Perry G, Siedlak SL et al (2002) Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans. Neurosci Lett 319:25-28
6. Castro JA (1984) Mechanistic studies and prevention of free radical cell injury. In: Paton W, Mitchell J, Turner P (eds) Proceedings of IUPHAR 9th International Congress Pharmacol, MacMillan
7. Cheeseman KH, Albono EF, Tomasi A et al (1985) Biochemical studies on the metabolic activity of halogenated alkanes. Environ Health Perspect 64:85-101
8. Chen YH, Lin FY, Liu PL et al (2009) Antioxidative and hepatoprotective effects of magnolol on acetaminophen-induced liver damage in rats. Arch Pharm Res 32:221-228
9. Chirino YI, Sánchez-González DJ, Martínez-Martínez CM et al (2008) Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology 245:18-23
10. Cooper AA, Gitler AD, Cashikar A et al (2006) Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson’s models. Science 313:324-328
11. Ekuni D, Tomofuji T, Sanbe T et al (2009) Periodontitis-induced lipid peroxidation in rat descending aorta is involved in the initiation of atherosclerosis. J Periodontal Res 44:434-442
12. Fillastre JP, Raguenez-Viotte G (1989) Cisplatin nephrotoxicity. Toxicol Lett 46:163-175
13. Forni LG, Packer JE, Slater TF et al (1983) Reaction of the trichloromethyl and halothane-derived peroxy radicals with unsaturated fatty acids: a pulse radiolysis study. Chem Biol Interact 45:171-177
14. Fukuchi Y, Miura Y, Nabeno Y et al (2008) Immunohistochemical detection of oxidative stress biomarkers, dityrosine and Nε-(hexanoyl)lysine, and c-reactive protein in rabbit atherosclerotic lesions. J Atheroscler Thromb 15:185-192
15. Fukuda M, Kanou F, Shimada N et al (2009) Elevated levels of 4-hydroxynonenal-histidine Michael adduct in the hippocampi of patients with Alzheimer’s disease. Biomed Res 30:227-233
16. Grant Maxie M, Robinson WF (2007) Cardiovascular system. In: Grant Maxie M (ed) Ubb, Kennedy, and Palmer’s pathology of domestic animals, vol 3, 5th edn. Sanders, New York
17. Greggi Antunes LM, Darin JDC, Biancii MLP (2000) Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study. Pharmacol Res 41:405-411
18. Hartley DP, Kolaja KL, Reichard J et al (1999) 4-Hydroxynoneal and malondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: immunohistochemical detection and lobular localization. Toxicol Appl Pharmacol 161:23-33
19. Higuchi Y (2003) Chromosomal DNA fragmentation in apoptosis and necrosis induced by oxidative stress. Biochem Pharmacol 66:1527-1535
20. Hinson JA, Roberts DW, James LP (2010) Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol 196:369-405
21. Hisaka S, Kato Y, Kitamoto N et al (2009) Chemical and immunochemical identification of propanoyllysine derived from oxidized n-3 polyunsaturated fatty acid. Free Radic Biol Med 46:1463-1471
22. Huang A, Sun D, Kaley G et al (1998) Superoxide released to high intra-arteriolar pressure reduces nitric oxide-mediated shear stress-and agonist-induced dilations. Circ Res 83:960-965
23. Jaeschke H, Bajt ML (2006) Intracellular signaling mechanisms of acetaminophen-induced liver cell death. Toxicol Sci 89:31-41
24. Jenner P (2003) Oxidative stress in Parkinson’s disease. Ann Neurol 53:S26-S36
25. Jomova K, Vondrakova D, Lawson M et al (2010) Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 345:91-104
26. Jones TW, Chopra S, Kaufman JS et al (1985) Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat. Correlation of structural and functional alterations. Lab Invest 52:363-374
27. Kato Y, Osawa T (2010) Detection of lipid-lysine amide-type adduct as a marker of PUFA oxidation and its applications. Arch Biochem Biophs 501:182-187
28. Kato Y, Mori Y, Makino Y et al (1999) Formation of Nepsilon-(hexanonyl)lysine in protein exposed to lipid hydroperoxide. A plausible marker for lipid hydroperoxide-derived protein modification. J Biol Chem 274:20406-20414
29. Kawai Y, Kato Y, Fujii H et al (2003) Immunochemical detection of a novel lysine adduct using an antibody to linoleic acid hydroperoxide-modified protein. J Lipid Res 44:1124-1131
30. Kawai Y, Fujii H, Kato Y et al (2004) Esterified lipid hydroperoxide-derived modification of protein: formation of a carboxyalkylamide-type lysine adduct in human atherosclerotic lesions. Biochem Biophys Res Commun 313:271-276
31. Kawai Y, Fujii H, Okada M et al (2006) Formation of Nε-(succinyl)lysine in vivo: a novel marker for docosahexaenoic acid-derived protein modification. J Lipid Res 47:1386-1398
32. Kim JS, He L, Lemasters JJ (2003) Mitochondrial permeability transition: a common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 304:463-470
33. Kristal BS, Park BK, Yu BP (1996) 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J Biol Chem 271:6033-6038
34. Kruidering M, Van de Water B, de Heer E (1997) Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complex I to IV of the respiratory chain. J Pharmacol Exp Ther 280:638-649
35. Larson AM, Polson J, Fontana RJ et al (2005) Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 42:1364-1372
36. Lee JY, Je JH, Kim DH et al (2004) Induction of endothelial apoptosis by 4-hydroxyhexenal. Eur J Biochem 271:1339-1347
37. Liu XY, Yang ZH, Pan XJ et al (2010) Crotonaldehyde induces oxidative stress and caspasedependent apoptosis in human bronchial epithelial cells. Toxicol Lett 195:90-98
38. Long EK, Murphy TC, Leiphon LJ et al (2008) Trans-4-hydroxy-2-hexenal is a neurotoxic product of docosahexaenoic (22:6; n-3) acid oxidation. J Neurochem 105:714-724
39. Masubuchi Y, Suda C, Horie T (2005) Involvement of mitochondrial permeability transition in acetaminophen-induced liver injury in mice. J Hepatol 42:110-116
40. Masuda H, Tanaka T, Takahama U (1994) Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun 203:1175-1180
41. McCay PB, Lai EK, Poyer JL et al (1984) Oxygen and carbon-centered free radical formation during carbon tetrachloride metabolism. J Biol Chem 259:2135-2143
42. Mitra S, Goyal T, Mehta JL (2011) Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drug Ther 25:419-429
43. Mügge A, Brandes RP, Böger RH et al (1994) Vascular release of superoxide radicals is enhanced in hypercholesterolemic rabbits. J Cardiovasc Pharmacol 24:994-998
44. Nelson SD (1990) Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin Liver Dis 10:267-278
45. Nicolls MR, Haskins K, Flores SC (2007) Oxidant stress, immune dysregulation, and vascular function in type I diabetes. Antioxid Redox Signal 9:879-889
46. Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73:994-1007
47. Recknagel RO, Glende EA Jr, Dolak JK et al (1989) Mechanisms of carbon tetrachloride toxicity. Pharmacol Ther 43:139-154
48. Reynolds ES (1963) Liver parenchymal cell injury. I. Initial alterations of the cell following poisoning with carbon tetrachloride. J Cell Biol 19:139-157
49. Rumack BH (2004) Acetaminophen misconceptions. Hepatology 40:10-15
50. Saito C, Yan HM, Artigues A et al (2010) Mechanism of protection by metallothionein against acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 242:182-190
51. Schmidley JW (1990) Free radicals in central nervous system ischemia. Stroke 21:1086-1090
52. Shamamoto-Nagai M, Maruyama W, Hashizume Y et al (2007) In Parkinsonian substantia nigra, alpha-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity. J Neural Transm 114:1559-1567
53. Sugiyama A, Sun J, Nishinohara M et al (2011) Expressions of lipid oxidation markers, Nε-hexanoyl lysine and acrolein in cisplatin-induced nephrotoxicity in rats. J Vet Med Sci 73:821-826
54. Sun J, Sugiyama A, Hisaka S et al (2012) Immunohistochemical detection of polyunsaturated fatty acid oxidation markers in acetaminophen-induced liver injury in rats. J Vet Med Sci 74:141-147
55. Tamer L, Sucu N, Polat G et al (2002) Decreased serum total antioxidant status and erythrocytereduced glutathione levels are associated with increased serum malondialdehyde in atherosclerotic patients. Arch Med Res 33:257-260
56. Uchida K (1999) Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc Med 9:109-113
57. Uchida K (2000) Role of reactive aldehyde in cardiovascular disease. Free Radic Biol Med 28:1685-1696
58. Uchida K, Kanematsu M, Sakai K et al (1998) Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci U S A 95:4882-4887
59. Weber LW, Boll M, Stampfl A (2003) Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33:105-136
60. Yao X, Panichpisal K, Kurtzman N et al (2007) Cisplatin nephrotoxicity: a review. Am J Med Sci 334:115-124
61. Yoritaka A, Hattori N, Uchida K et al (1996) Immunohistochemical detection of 4-hydroxynoneal protein adducts in Parkinson disease. Proc Natl Acad Sci U S A 93:2696-2701
62. Yoshida T, Adachi E, Nigi H et al (1999) Changes of sinusoidal basement membrane collagens in early hepatic fibrosis induced with CCl4 in cynomolgus monkeys. Pathology 31:29-35
63. Zarkovic K (2003) 4-Hydroxynoneal and neurodegenerative diseases. Mol Aspect Med 24:293-303
64. Zhou H, Kato A, Yasuda H et al (2004) The induction of cell cycle regulatory and DNA repair proteins in cisplatin-induced acute renal failure. Toxicol Appl Pharmacol 200:111-120
65. Zhou H, Kato A, Miyaji T et al (2006) Urinary marker for oxidative stress in kidneys in cisplatininduced acute renal failure in rats. Nephrol Dial Transplant 21:616-623